World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
33732
World Ranking
12567
National Ranking
6432

Overview

Maher Albitar is affiliated with the Genomic Testing Cooperative in the United States and has focused their research primarily within the field of medicine, contributing to various subfields including hematology, cancer research, pulmonary and respiratory medicine, genetics, and pathology and forensic medicine.

Their scientific contributions extend to key topics such as acute myeloid leukemia research, lymphoma diagnosis and treatment, cancer genomics and diagnostics, chronic lymphocytic leukemia research, platelet disorders and treatments, myeloproliferative neoplasms diagnosis and treatment, and hematopoietic stem cell transplantation.

Frequent publication venues where Maher Albitar has disseminated their research include:

  • Blood
  • Journal of Clinical Oncology
  • Scandinavian Journal of Urology
  • The American Journal of Gastroenterology
  • Haematologica

Maher Albitar's recent peer-reviewed articles feature studies on prognostic modeling, treatment outcomes, and biomarker research. Selected notable papers include:

  • Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model, 2020, Journal of Clinical Oncology
  • Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome, 2020, Haematologica
  • Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias, 2020, Blood Advances
  • Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data, 2023, Breast Cancer Basic and Clinical Research
  • A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohort, 2020, Scandinavian Journal of Urology

Collaborative work has involved multiple frequent coauthors, including André Goy, Andrew Ip, Andrew L. Pecora, Ahmad Charifa, and Sally Agersborg.

Best Publications

  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

    Hagop Kantarjian;Jean-Pierre J. Issa;Craig S. Rosenfeld M.D.;John M. Bennett

  • Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

    Hagop M Kantarjian;Francis Giles;Lydia Wunderle;Kapil Bhalla

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

    Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner

  • Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

    Michael J. Keating;Ian Flinn;Vinay Jain;Jacques-Louis Binet

  • Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.

    Martin Körbling;Ruth L. Katz;Abha Khanna;Arnout C. Ruifrok

  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

    Alvaro Aguayo;Hagop M Kantarjian;Taghi Manshouri;Cristi Gidel

  • Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia

    William Wierda;Susan O'Brien;Sijin Wen;Stefan Faderl

  • CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

    Sherif Ibrahim;Michael Keating;Kim Anh Do;Susan O'Brien

  • Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

    Christina A. Meyers;Maher Albitar;Elihu Estey

  • Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity

    Elizabeth Oldham Hileman;Jinsong Liu;Maher Albitar;Michael J. Keating

  • Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia.

    Alvaro Aguayo;Elihu Estey;Elihu Estey;Hagop M Kantarjian;Hagop M Kantarjian;Taghi Mansouri;Taghi Mansouri

  • B-cell clones as early markers for chronic lymphocytic leukemia.

    Ola Landgren;Maher Albitar;Wanlong Ma;Fatima Abbasi

  • Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

    Francesco Onida;Hagop M. Kantarjian;Terry L. Smith;Greg Ball

  • Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial

    David P. Steensma;Maria R. Baer;James L. Slack;Rena Buckstein

  • Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies

    Karen W.L. Yee;Zhihong Zeng;Marina Konopleva;Srdan Verstovsek

  • The human MDM-2 oncogene is overexpressed in leukemias.

    Carlos E. Bueso-Ramos;Yun Yang;Elizabeth deLeon;Patrick McCown

  • A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies

    Francis Giles;Thomas Fischer;Jorge Cortes;Guillermo Garcia-Manero

  • Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia

    Deborah A. Thomas;Jorge Cortes;Susan O'Brien;Sherry Pierce

  • Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

    Inhye E. Ahn;Chingiz Underbayev;Adam Albitar;Sarah E. M. Herman

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Francis J. Giles
Francis J. Giles Northwestern University
Susan O'Brien
Susan O'Brien University of California, Irvine
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Zeev Estrov
Zeev Estrov The University of Texas MD Anderson Cancer Center
Elihu H. Estey
Elihu H. Estey University of Washington
Mahmoud Aljurf
Mahmoud Aljurf King Faisal Specialist Hospital & Research Centre
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Alessandra Ferrajoli
Alessandra Ferrajoli The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many related online degrees and career pathways in healthcare. For those interested in health and wellness outside of traditional medicine, an online nutritionist degree can lead to a rewarding career promoting healthy lifestyles and disease prevention.

Advancing into healthcare management is possible through the best online mha programs, which equip students for leadership roles in hospitals and other medical institutions.

Registered nurses seeking to grow their qualifications without interrupting their work can consider the best online rn to bsn programs without clinical requirements, providing flexibility and quicker completion times.

Ambitious nurses aspiring for the highest level of clinical practice might explore a 1 year dnp program online, offering a fast track to leadership and advanced practice.

Each of these programs supports specialized pathways in health professions, helping students tailor their careers to evolving industry demands.

Best Scientists Citing Maher Albitar

Trending Scientists

Recently Published Articles